news 2018



Results 81 - 100 of 1765.

Health - Life Sciences - 07.12.2018
Bacterial 'sleeper cells' evade antibiotics and weaken defence against infection
Bacterial ’sleeper cells’ evade antibiotics and weaken defence against infection
New research, from scientists at Imperial College London, unravels how so-called bacterial persister cells manipulate our immune cells. The work potentially opens new avenues to finding ways of clearing these bacterial cells from the body, and stopping recurrence of the bacterial infection. The latest findings may help explain why some people suffer from repeated bouts of an illness, despite taking antibiotics.

Life Sciences - Health - 07.12.2018
News About a Plant Hormone
News About a Plant Hormone
The plant hormone jasmonic acid also performs a function that was previously unknown. It ensures that the leaf pores close when leaves are injured. For the plant, this could be an emergency signal. Jasmonic acid is not just the aromatic odor of the plant Jasminum grandiflorum used in cosmetics and perfume industries.

Health - Life Sciences - 07.12.2018
Link between neonatal vitamin D deficiency and schizophrenia confirmed
Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported. The discovery could help prevent some cases of the disease by treating vitamin D deficiency during the earliest stages of life. The study, led by Professor John McGrath from The University of Queensland and Aarhus University in Denmark, found newborns with vitamin D deficiency had a 44 per cent increased risk of being diagnosed with schizophrenia as adults compared to those with normal vitamin D levels.

Life Sciences - Health - 07.12.2018
Engineers repurpose wasp venom as an antibiotic drug
Engineers repurpose wasp venom as an antibiotic drug
Altered peptides from a South American wasp's venom can kill bacteria but are nontoxic to human cells. The venom of insects such as wasps and bees is full of compounds that can kill bacteria. Unfortunately, many of these compounds are also toxic for humans, making it impossible to use them as antibiotic drugs.

Health - Life Sciences - 07.12.2018
Predicting the transmission of rare, genetically based diseases
There are only 25 people in the whole of Quebec at the moment who have a rare recessive genetic disease called chronic atrial and intestinal dysrhythmia (CAID). It is a serious disease that affects both heart rate and intestinal movements. A McGill-led research team has been able to trace the gene mutations underlying the disease back to two European founding families who arrived in the province in the 17th century.

Health - Pharmacology - 06.12.2018
Statins Overprescribed for Primary Prevention
Taking cholesterol-lowering drugs, or statins, as a preventive measure can reduce the risk of cardiovascular disease. A study by the University of Zurich now shows that this measure is recommended too often, as current guidelines fail to take into account the risks of side effects. Even healthy people who don't suffer from a cardiovascular disease are prescribed cholesterol-lowering drugs, known as statins, if they meet certain risk criteria.

Pharmacology - Health - 06.12.2018
Half a Million Tests and Many Mosquitoes Later, New Buzz about a Malaria Prevention Drug
Researchers tested chemical compounds for their ability to inhibit the malaria parasite at an earlier lifecycle stage than most current drugs, revealing chemical starting points for new malaria preventatives Most malaria drugs are designed to reduce symptoms after infection. They work by blocking replication of the disease-causing parasites in human blood, but they don't prevent infection or transmission via mosquitoes.

Health - 06.12.2018
Survey reveals bovine TB in a fifth of roadkill badgers in Cheshire
The first study to test for bovine tuberculosis in badgers on the edge of the cattle TB epidemic in England, has shown that one in five badgers tested positive for the disease. The pilot survey was carried out on road-killed badgers collected in Cheshire in 2014 through a local stakeholder TB Group that included farmers, wildlife groups and vets.

Life Sciences - Health - 06.12.2018
Silicosis is on the rise, but is there a therapeutic target ?
Silicosis is on the rise, but is there a therapeutic target ?
Paris, 6 December 2018 Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, which leads to silicosis, an incurable disease. Their study in mice and patients, published (December 6th, 2018), shows that this inflammation can be prevented by extracellular DNA degradation, suggesting a new therapeutic target.

Health - Life Sciences - 06.12.2018
Another Medical Cold Case Cracked by the MUHC’s ’Dr. House’
Team of RI-MUHC researchers discover new disease and its genetic cause in Quebec patient as "Bubble Boy" symptoms discovered in adults for first time A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI's so-called "Dr. House" because of his research into rare diseases, has discovered a new human disease and the gene responsible for it, paving the way for the proper diagnosis of patients globally and the development of new therapies.

Health - Life Sciences - 05.12.2018
New genetic insight could help treat rare debilitating heart and lung condition
New genetic insight could help treat rare debilitating heart and lung condition
The largest study of genetic variation in patients with pulmonary arterial hypertension has associated two important genes with the disease. In collaboration with institutes from Europe and Northern America, researchers from Imperial College London have conducted the largest genetic analysis to date of 2,000 patients with pulmonary arterial hypertension (PAH) and identified associations with two genes.

Health - Life Sciences - 05.12.2018
Belgian team secures million-dollar funding from Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative (CZI), the philanthropic endeavour led by Facebook's Mark Zuckerberg and his partner Priscilla Chan, has announced the launch of its Neurodegeneration Challenge Network. This new network brings together experimental scientists from various biomedical research fields, computational biologists, and physicians to understand the underlying causes of neurodegenerative disorders.

Health - Pharmacology - 05.12.2018
Opioid prescriptions from dentists linked to youth addiction risk
In teenagers and young adults, receiving opioids from dental providers is linked with elevated risk for continued opioid use and abuse, a Stanford study has found. Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine has found.

Life Sciences - Health - 05.12.2018
Whole-brain imaging of mice during behavior
In a study published in Neuron, researchers have demonstrated how functional ultrasound imaging can yield high-resolution, unbiased, brain-wide activity maps of behaving mice. These can lead to a brain-wide understanding of how brain activity relates to specific behavior - in healthy mice and in mouse models of neurologic or psychiatric diseases.

Health - Life Sciences - 05.12.2018
UC San Diego Researchers Develop Sensors to Detect and Measure Cancer’s Ability to Spread
The spread of invasive cancer cells from a tumor's original site to distant parts of the body is known as metastasis. It is the leading cause of death in people with cancer. In a paper published online in iScience , University of California San Diego School of Medicine researchers reported engineering sensors that can detect and measure the metastatic potential of single cancer cells.

Health - Life Sciences - 05.12.2018
Newly identified'T cells could play a role in cancer and other diseases
Newly identified’T cells could play a role in cancer and other diseases
Health + Behavior UCLA RESEARCH ALERT Duane Bates FINDINGS Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute of Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the molecules that help form cells' outer membranes.

Health - 05.12.2018
Patient-carer relationships disrupted by hospital reorganisation
Research from King's College London suggests that reorganisation of mental health services can have a negative effect on the health of people with severe mental illness, due to the disruption of relationships between patients and carers. Lasting relationships between people with severe mental illness and healthcare professionals are prized by patients, doctors and policymakers.

Health - Physics - 05.12.2018
Nano-signature discovery could revolutionise cancer diagnosis
Nano-signature discovery could revolutionise cancer diagnosis
A quick and easy test to detect cancer from blood or biopsy tissue could eventually result in a new approach to patient diagnosis. The test has been developed by University of Queensland researchers Dr Abu Sina , Dr Laura Carrascosa and Professor Matt Trau , who have discovered a unique DNA nanostructure that appears to be common to all cancers.

Health - Life Sciences - 04.12.2018
Chopping unlocks new function in protein linked to dementia
Scientists have uncovered an unexpected new role for a protein that may underlie rare diseases. A protein, called p62, is chopped by molecular scissors to help cells realise that they are 'hungry', encouraging them to break down and consume old material in the cell. This helps them to stay healthy and fight off infection.

Life Sciences - Health - 04.12.2018
Learning from Mistakes
Everyone makes little everyday mistakes out of habit-a waiter says, "Enjoy your meal," and you respond with, "You, too!" before realizing that the person is not, in fact, going to be enjoying your meal. Luckily, there are parts of our brains that monitor our behavior, catching errors and correcting them quickly.